Gene Amplification technology is one of the rapidly growing markets in life science field. By the year 2015, global market for Gene Amplification technologies is projected to reach $2.2 billion. Major factors that continue to affect the industry are patent expiry, and competitive advantages associated with the existing and emerging technologies.
San Jose, CA (PRWEB) November 4, 2008 -- Molecular diagnostics and the Human Genome Project (HGP) have been the major growth drivers for gene amplification technology. Amplification is a mechanism by which cells are amplified or synthesized from a single copy of gene. Gene amplification technology addresses applications in molecular biology research (DNA amplification), gene therapy, drug discovery, forensic identification, and diagnosis.
World gene amplification technologies market is dominated by United States, Europe, and Japan, accounting for 90% of the world market in 2008, as stated in a recent report published by Global Industry Analysts, Inc. United States represents the most sought after market in terms of both market size and growth opportunities, with a projected CAGR of more than 7.5% over the period through 2015.
Polymerase Chain Reaction (PCR) dominates the global gene therapy market, with revenues estimated at US$864 million in 2008. However, growth in the PCR market is projected to slide down in the near term in wake of increasing applications and development of alternative technologies that challenge PCR in several areas. Alternative technologies to PCR are forecast to display strong growth in the US, Europe, and Japan. Some of the alternative technologies existing in the market include OmniPlex, Strand Displacement Amplification (SDA), Ligase Chain Reaction (LCR), and Hybrid Capture technology.
Gene amplification technology plays a vital role in the diagnostics field. With increasing aging population, countries worldwide face the challenge of preventing age-related diseases such as cardiovascular diseases and diabetes. This indicates the requirement of new diagnostics including genetic testing which make use of gene amplification technology. With the growing improvements in the diagnostic market, the DNA diagnostic technologies are set to achieve superior efficiencies and improved activity in numerous application areas, including healthcare, biomedical research, toxicology, bioremediation, forensics and personnel identification, environmental monitoring, quality control in the food industry, and agriculture.
Leading players profiled in the report include Bio Merieux, Bio-Rad Laboratories Cepheid, Roche Diagnostics, Rubicon Genomics, and Takara Bio.
The report titled "Gene Amplification Technologies: A Global Strategic Business Report" published by Global Industry Analysts, Inc., analyzes the market across the US, Canada, Japan, Europe, and Rest of World. Product segments analyzed in the report include PCR and Other Gene Amplification Technologies. The report enumerates recent developments, mergers, acquisitions and other strategic industry activities. Analysis is provided in US$ Million for the period 2000-2015.
For more details about this research report, please visit http://www.strategyr.com/Gene_Amplification_Technologies_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Email press @ StrategyR.com
Web Site http://www.StrategyR.com/
Read the full story at http://www.prweb.com/releases/gene_amplification/technologies_PCR/prweb1563384.htm
Copyright©2008 Vocus, Inc.
All rights reserved